Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Amita Patnaik's publication output changed over time?
ScholarIQpublication output · 2013–2015
Output grew0% over the shown period — from 1 works in 2013 to 1 in 2015.
1
1
20132015
What are the most-cited papers on Amita Patnaik?
ScholarIQmost cited works
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
New England Journal of Medicine. 20156,260 CitationsOPEN ACCESS
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Omid Hamid, Caroline Robert, Adil Daud, F. Stephen Hodi, Wen-Jen Hwu, Richard Kefford, Jedd D. Wolchok, Peter Hersey, Richard W. Joseph, Jeffrey S. Weber, Roxana Dronca, Tara C. Gangadhar, Amita Patnaik, Hassane M. Zarour, Anthony M. Joshua, Kevin Gergich, Jeroen Elassaiss‐Schaap, Alain P. Algazi, Christine Mateus, Peter D. Boasberg, Paul C. Tumeh, Bartosz Chmielowski, Scot Ebbinghaus, Xiaoyun Li, Sunyu Kang, Antoni Ribas
New England Journal of Medicine. 20133,407 CitationsOPEN ACCESS
Related on ScholarIQ
South Texas Accelerated Research Therapeutics
University
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Paper
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
Paper
Monoclonal and Polyclonal Antibodies Research
Topic
Cancer Immunotherapy and Biomarkers
Topic
Lung Cancer Treatments and Mutations
Topic